Literature DB >> 22920885

Structural insights into the molecular basis of the ligand promiscuity.

Noé Sturm1, Jérémy Desaphy, Ronald J Quinn, Didier Rognan, Esther Kellenberger.   

Abstract

Selectivity is a key factor in drug development. In this paper, we questioned the Protein Data Bank to better understand the reasons for the promiscuity of bioactive compounds. We assembled a data set of >1000 pairs of three-dimensional structures of complexes between a "drug-like" ligand (as its physicochemical properties overlap that of approved drugs) and two distinct "druggable" protein targets (as their binding sites are likely to accommodate "drug-like" ligands). Studying the similarity between the ligand-binding sites in the different targets revealed that the lack of selectivity of a ligand can be due (i) to the fact that Nature has created the same binding pocket in different proteins, which do not necessarily have otherwise sequence or fold similarity, or (ii) to specific characteristics of the ligand itself. In particular, we demonstrated that many ligands can adapt to different protein environments by changing their conformation, by using different chemical moieties to anchor to different targets, or by adopting unusual extreme binding modes (e.g., only apolar contact between the ligand and the protein, even though polar groups are present on the ligand or at the protein surface). Lastly, we provided new elements in support to the recent studies which suggest that the promiscuity of a ligand might be inferred from its molecular complexity.

Mesh:

Substances:

Year:  2012        PMID: 22920885     DOI: 10.1021/ci300196g

Source DB:  PubMed          Journal:  J Chem Inf Model        ISSN: 1549-9596            Impact factor:   4.956


  17 in total

1.  Interplay of physics and evolution in the likely origin of protein biochemical function.

Authors:  Jeffrey Skolnick; Mu Gao
Journal:  Proc Natl Acad Sci U S A       Date:  2013-05-20       Impact factor: 11.205

2.  A benchmark driven guide to binding site comparison: An exhaustive evaluation using tailor-made data sets (ProSPECCTs).

Authors:  Christiane Ehrt; Tobias Brinkjost; Oliver Koch
Journal:  PLoS Comput Biol       Date:  2018-11-08       Impact factor: 4.475

3.  Binding site characterization - similarity, promiscuity, and druggability.

Authors:  Christiane Ehrt; Tobias Brinkjost; Oliver Koch
Journal:  Medchemcomm       Date:  2019-06-06       Impact factor: 3.597

4.  How promiscuous are pharmaceutically relevant compounds? A data-driven assessment.

Authors:  Ye Hu; Jürgen Bajorath
Journal:  AAPS J       Date:  2012-10-23       Impact factor: 4.009

5.  Ethionamide Pharmacokinetics/Pharmacodynamics-derived Dose, the Role of MICs in Clinical Outcome, and the Resistance Arrow of Time in Multidrug-resistant Tuberculosis.

Authors:  Devyani Deshpande; Jotam G Pasipanodya; Stellah G Mpagama; Shashikant Srivastava; Paula Bendet; Thearith Koeuth; Pooi S Lee; Scott K Heysell; Tawanda Gumbo
Journal:  Clin Infect Dis       Date:  2018-11-28       Impact factor: 9.079

6.  On the role of physics and evolution in dictating protein structure and function.

Authors:  Jeffrey Skolnick; Mu Gao; Hongyi Zhou
Journal:  Isr J Chem       Date:  2014-08-01       Impact factor: 3.333

7.  Structure-Activity Relationships in Metal-Binding Pharmacophores for Influenza Endonuclease.

Authors:  Cy V Credille; Benjamin L Dick; Christine N Morrison; Ryjul W Stokes; Rebecca N Adamek; Nicholas C Wu; Ian A Wilson; Seth M Cohen
Journal:  J Med Chem       Date:  2018-10-31       Impact factor: 7.446

8.  Creation of a free, Internet-accessible database: the Multiple Target Ligand Database.

Authors:  Chao Chen; Yang He; Jianhui Wu; Jinming Zhou
Journal:  J Cheminform       Date:  2015-04-15       Impact factor: 5.514

Review 9.  Exploring compound promiscuity patterns and multi-target activity spaces.

Authors:  Ye Hu; Disha Gupta-Ostermann; Jürgen Bajorath
Journal:  Comput Struct Biotechnol J       Date:  2014-01-29       Impact factor: 7.271

10.  Physicochemical characteristics of structurally determined metabolite-protein and drug-protein binding events with respect to binding specificity.

Authors:  Paula Korkuć; Dirk Walther
Journal:  Front Mol Biosci       Date:  2015-09-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.